![Frontiers | The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future Frontiers | The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future](https://www.frontiersin.org/files/Articles/671961/fpubh-09-671961-HTML-r1/image_m/fpubh-09-671961-t002.jpg)
Frontiers | The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
Insulin Icodec - the once a week long acting insulin from Novo Nordisk | Diabettech - Diabetes and Technology
![The promising future of insulin therapy in diabetes mellitus | American Journal of Physiology-Endocrinology and Metabolism The promising future of insulin therapy in diabetes mellitus | American Journal of Physiology-Endocrinology and Metabolism](https://journals.physiology.org/cms/10.1152/ajpendo.00608.2020/asset/images/medium/e-00608-2020r01.png)
The promising future of insulin therapy in diabetes mellitus | American Journal of Physiology-Endocrinology and Metabolism
![PDF] A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naïve People With Type 2 Diabetes | Semantic Scholar PDF] A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naïve People With Type 2 Diabetes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/70f0bb214ea2ff0f2d98155885e4bc57202ac108/2-Table1-1.png)
PDF] A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naïve People With Type 2 Diabetes | Semantic Scholar
![A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes | Scientific Reports A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-83253-6/MediaObjects/41598_2021_83253_Fig1_HTML.png)